There are 3161 resources available
Round table discussion and Q&A
Presenter: Sibylle Loibl, Marion Kiechle, Victor Navarro, Donal Brennan
Session: Bayer - Managing menopausal symptoms in patients undergoing endocrine therapy due to hormone-receptor positive breast cancer
Resources:
Webcast
Discussion
Presenter: Noemi Reguart Aransay, Antonio Passaro, Sanjay Popat, Alexander Spira, Enriqueta Felip
Session: Johnson & Johnson - Driving EGFR-mutant NSCLC care forward
Resources:
Webcast
Close
Presenter: Sibylle Loibl
Session: Bayer - Managing menopausal symptoms in patients undergoing endocrine therapy due to hormone-receptor positive breast cancer
Resources:
Webcast
Closing remarks
Presenter: Antonio Passaro
Session: Johnson & Johnson - Driving EGFR-mutant NSCLC care forward
Resources:
Webcast
Understanding resistance in immunotherapy
Presenter: Jarushka Naidoo
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Slides
Webcast
Patients’ involvement in immunotherapy trials design
Presenter: Anne-Marie Baird
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Slides
Webcast
New indications for immunotherapies and the difference they deliver: Lung, breast, and other cancers. Does it work for all?
Presenter: Jean-Pascal Machiels
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Slides
Webcast
Side effects of immunotherapy, and how to deal with patients' health problems
Presenter: Michal Jarzab
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Slides
Webcast
Access to immunotherapies in Poland and in Spain based on EMA and ESMO guidance
Presenter: Agata Polinska
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Slides
Webcast
Discussion
Session: Immunotherapy: New indications, hopes and perspectives
Resources:
Webcast